<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02918344</url>
  </required_header>
  <id_info>
    <org_study_id>Calciumfosfaat cement</org_study_id>
    <nct_id>NCT02918344</nct_id>
  </id_info>
  <brief_title>Complications From the Use of Calcium Phosphate Paste in Mandibular Lengthening Osteotomies</brief_title>
  <official_title>Prospective Study: Complications From the Use of Calcium Phosphate Paste in Mandibular Lengthening Osteotomies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to determine if the use of calcium phosphate paste in mandibular&#xD;
      lengthening surgery causes more complications as surgical site infections and hardware&#xD;
      removal.&#xD;
&#xD;
      An evaluation will be made to determine if the benefits of the use of the paste&#xD;
      (3D-stability, prevention of early relapse and unaesthetic indentation) outweighs the&#xD;
      disadvantages.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The sagittal split osteotomy (SSO) is commonly used to correct dentofacial discrepancies.&#xD;
      Correction of distocclusion can be achieved through lengthening of the mandible, and a&#xD;
      balanced facial appearance can be obtained by increasing chin projection.&#xD;
&#xD;
      Calcium phosphate paste is used in mandibular lengthening surgery to avoid an unaesthetic&#xD;
      notching at the lower border(1)(2) and to help stabilize the segments when osteosynthesis&#xD;
      slippage is feared for. A recently performed retrospective study showed an increase of&#xD;
      infectious complications when calcium phosphate paste was used for this indications. Several&#xD;
      precautions were identified that could be undertaken to decrease the infectious&#xD;
      complications. The study concluded that a prospective study was required in which these&#xD;
      precautions were implemented to determine whether infectious complications can be reduced.&#xD;
&#xD;
      The aim of this study is to investigate whether the hardened paste still increases the&#xD;
      incidence of site infections after implementation of several precautions and the use of a&#xD;
      standardized antibiotic prophylactic protocol.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical site infection</measure>
    <time_frame>6 months</time_frame>
    <description>Determine the number of surgical site infection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hardware removal</measure>
    <time_frame>6 months</time_frame>
    <description>Determine the number of hardware removal</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revision</measure>
    <time_frame>6 months</time_frame>
    <description>Determine the number of revisions</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">192</enrollment>
  <condition>Jaw Anomalies</condition>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>Standard sagittal split osteotomy group</arm_group_label>
    <description>Patients undergoing sagittal split osteotomy without paste application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort/Hydroset group</arm_group_label>
    <description>Patients undergoing sagittal split osteotomy with paste application</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hydroset</intervention_name>
    <description>Calcium phosphate paste is used in mandibular lengthening surgery to avoid an unaesthetic notching at the lower border and to help stabilize the segments when osteosynthesis slippage is feared for.</description>
    <arm_group_label>Cohort/Hydroset group</arm_group_label>
    <arm_group_label>Standard sagittal split osteotomy group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard sagittal split osteotomy</intervention_name>
    <description>The sagittal split osteotomy (SSO) is commonly used to correct dentofacial discrepancies.</description>
    <arm_group_label>Cohort/Hydroset group</arm_group_label>
    <arm_group_label>Standard sagittal split osteotomy group</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      microbiological smear in case of infection&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing bilateral sagittal split osteotomy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients with dysgnatic deformities requiring mandibular lengthening surgery&#xD;
&#xD;
          -  Gender: M/F&#xD;
&#xD;
          -  Age: &gt;15y-75y&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous orthognathic surgery&#xD;
&#xD;
          -  Congenital facial malformations&#xD;
&#xD;
          -  Unilateral SSO&#xD;
&#xD;
          -  Immunodeficiency&#xD;
&#xD;
          -  Simultaneous removal of lower third molars&#xD;
&#xD;
          -  Incomplete postoperative follow-up&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erica Coppey, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maurice Mommaerts, Prof.Dr.Mult</last_name>
    <role>Study Director</role>
    <affiliation>Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Veerle Van Mossevelde, Data Nurse</last_name>
    <phone>+32 2 476 31 34</phone>
    <email>veerle.vanmossevele@uzbrussel.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>universitair Ziekenhuis brussel</name>
      <address>
        <city>Jette</city>
        <state>Brussels</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veerle Van Mossevelde, datanurse</last_name>
      <phone>+32 2 476 31 34</phone>
      <email>veerle.vanmossevelde@uzbrussel.be</email>
    </contact>
    <contact_backup>
      <last_name>Annelies De Cock, datanurse</last_name>
      <phone>+32 2 474 99 06</phone>
      <email>annelies.decock@uzbrussel.be</email>
    </contact_backup>
    <investigator>
      <last_name>Erica Coppey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>September 27, 2016</study_first_submitted>
  <study_first_submitted_qc>September 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2016</study_first_posted>
  <last_update_submitted>August 23, 2019</last_update_submitted>
  <last_update_submitted_qc>August 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Veerle Van Mossevelde</investigator_full_name>
    <investigator_title>Datanurse</investigator_title>
  </responsible_party>
  <keyword>calcium phosphate paste</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

